Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Aoxing Pharmaceutical Company, Inc. (AOXG : OTC)

• Company Description    Aoxing Pharmaceutical Company, Inc. is a pharmaceutical company engaged in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. It has international strategic alliances with QRxPharma Limited and American Oriental Bioengineering, Inc. in commercializing narcotic and pain management products for China and ex-China markets. The Company is working closely with the Chinese government and SFDA to assure the strictly regulated availability to medical professionals of its narcotic drugs and pain medicines throughout China. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang City, China. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.01 Daily Weekly Monthly 20 Day Moving Average: 10,388 shares Shares Outstanding: 381.21 (millions) Market Capitalization: $2.86 (millions) Beta: 6.73 52 Week High: $0.02 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -3.74% 12 Week -6.25% -21.14% Year To Date 5.63% -1.07%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE - SHIJIAZHUANG CITY,F4 94404 CHN ph: 86-311-8961-8579 fax: 646-367-1747 investor.relations@aoxingpharma.com None

• General Corporate Information    Officers Zhenjiang Yue - Chief Executive Officer; Director Zheng James Chen - Chief Financial Officer Yang Li - Director Jun Min - Director Guozhu Xu - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 03740A106 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: 09/01/24 Next Expected EPS Date: - Share - Related Items Shares Outstanding: 381.21 Most Recent Split Date: 3.00 (0.50:1) Beta: 6.73 Market Capitalization: $2.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©